ImmunoGen, Inc. (IMGN) Social Stream



ImmunoGen, Inc. (IMGN): $14.63

0.14 (-0.95%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add IMGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#94 of 360

in industry

IMMUNOGEN INC (IMGN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMGN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 7 $12 $5 $7.9 $14.77 -46.51%
2021-12-01 7 $12 $5 $8.9 $14.77 -39.74%
2022-02-02 7 $12 $6.5 $9.3 $14.77 -37.03%
2022-02-11 8 $18 $6.5 $10.75 $14.77 -27.22%
2022-03-09 8 $18 $5 $10.416 $14.77 -29.48%
2022-03-20 9 $18 $5 $10.416 $14.77 -29.48%
2022-03-21 9 $18 $5 $9.642 $14.77 -34.72%
2022-05-06 9 $18 $5 $9.571 $14.77 -35.2%
2022-08-01 9 $18 $4 $9.666 $14.77 -34.56%
2022-08-10 9 $18 $4 $9.428 $14.77 -36.17%
2022-08-31 9 $18 $4 $9.285 $14.77 -37.14%
2022-09-09 9 $18 $4 $9.125 $14.77 -38.22%
2022-11-07 10 $18 $4 $9.125 $14.77 -38.22%
2022-11-15 10 $18 $4 $9.25 $14.77 -37.37%
2022-11-16 11 $20 $4 $11 $14.77 -25.52%
2022-11-28 12 $20 $4 $10.9 $14.77 -26.2%
2023-01-05 12 $19.001 $4 $10.4 $14.77 -29.59%
2023-02-27 12 $19.001 $4 $10.5 $14.77 -28.91%
2023-03-02 12 $19.001 $3 $10.4 $14.77 -29.59%
2023-04-28 11 $19.001 $3 $10.889 $14.77 -26.28%
2023-05-01 11 $19.001 $3 $11 $14.77 -25.52%
2023-05-03 11 $19.001 $5 $13.222 $14.77 -10.48%
2023-05-09 11 $19.001 $8 $13.555 $14.77 -8.23%
2023-06-05 11 $19.001 $8 $13.889 $14.77 -5.96%
2023-06-06 11 $19.001 $8 $14.333 $14.77 -2.96%
2023-06-13 11 $21 $8 $16.222 $14.77 9.83%
2023-06-16 11 $24 $8 $17.111 $14.77 15.85%
2023-07-18 11 $24 $8 $18 $14.77 21.87%
2023-07-27 11 $24 $8 $18.444 $14.77 24.87%
2023-08-01 11 $24 $8 $19 $14.77 28.64%
2023-08-02 11 $27 $9.001 $22 $14.77 48.95%
2023-08-29 11 $27 $9.001 $22.111 $14.77 49.7%
2023-09-13 11 $27 $13 $23.555 $14.77 59.48%

The Trend in the Analyst Price Target


IMGN's average price target has moved up $13.34 over the prior 30 months.

IMGN reports an average of 75.4% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-15 11 18.000 4.000 9.375 5.010 87.13%
2022-11-21 12 20.000 4.000 10.900 5.320 104.89%
2023-03-02 12 19.001 3.000 10.400 4.450 133.71%
2023-05-03 11 19.001 5.000 13.222 12.260 7.85%
2023-08-01 11 26.000 9.001 21.000 18.245 15.1%

IMGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.18 10 0 1 0 0 11

The Trend in the Broker Recommendations


Over the past 52 weeks, IMGN's average broker recommendation rating improved by 0.62.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, IMMUNOGEN INC's upside potential (average analyst target price relative to current price) is higher than 506.92% of them.
  • IMGN has a lower variance in analysts' estimates than -3165.96% of all US stocks.
  • In terms of how IMMUNOGEN INC fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 556.49% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, IMMUNOGEN INC's number of analysts covering the stock is higher than 2710% of them.

In the Pharmaceutical Products industry, HRTX, ADCT, and ROIV are the three stocks most similar to IMMUNOGEN INC regarding the price target and analyst recommendation information presented here.

What is the outlook for IMGN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!